Clinical trial
A Multi-center, Randomized, Double Blind, Parallel-arm, Placebo Controlled Trial of Mepolizumab for Treatment of Adults and Adolescents With Active Eosinophilic Esophagitis and Dysphagia-predominant Symptoms
NCT03656380 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Randomized, Double Blind, Parallel-arm, Placebo Controlled Trial of Mepolizumab for Treatment of Adults and Adolescents With Active Eosinophilic Esophagitis and Dysphagia-predominant Symptoms
- Lead sponsor
- University of North Carolina, Chapel Hill
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 20, 2019
- Completion date
- December 9, 2022
- Enrollment
- 66 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.